|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.503 CHF | -4.29% |
|
-10.60% | -17.74% |
| Mar. 04 | Nxera Pharma Co., Ltd. Submits Marketing Authorization Application For Daridorexant In South Korea | CI |
| Feb. 27 | Idorsia Ltd Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Capitalization | 921M 1.18B 1.02B 884M 1.61B 108B 1.68B 10.89B 4.35B 51.72B 4.41B 4.32B 185B | P/E ratio 2026 * |
-9.83x | P/E ratio 2027 * | 61.7x |
|---|---|---|---|---|---|
| Enterprise value | 1.95B 2.5B 2.16B 1.88B 3.42B 229B 3.57B 23.12B 9.24B 110B 9.37B 9.17B 394B | EV / Sales 2026 * |
7.37x | EV / Sales 2027 * | 7.53x |
| Free-Float |
63.29% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Idorsia Ltd
| Jan. 06 | Swiss stocks - Factors to watch on January 6 | RE |
| 25-10-30 | Swiss stocks - Factors to watch on October 30 | RE |
| 25-10-10 | Swiss stocks - Factors to watch on October 10 | RE |
| 25-10-09 | Idorsia primary ABB orders below CHF 4.00 risk missing, says bookrunner | RE |
| 25-02-26 | Swiss stocks - Factors to watch on February 26 | RE |
| 1 day | -4.29% | ||
| 1 week | -10.60% | ||
| Current month | -10.60% | ||
| 1 month | -2.78% | ||
| 3 months | -9.21% | ||
| 6 months | +14.01% | ||
| Current year | -17.74% |
| 1 week | 3.3 |  | 4.18 |
| 1 month | 3.3 | | 4.32 |
| Current year | 3.3 | | 4.65 |
| 1 year | 0.85 | | 4.85 |
| 3 years | 0.61 | | 13.08 |
| 5 years | 0.61 | | 27.1 |
| 10 years | 0.61 | | 33.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Srishti Gupta
CEO | Chief Executive Officer | 49 | 2025-06-30 |
Martine Clozel
CTO | Chief Tech/Sci/R&D Officer | 70 | 2017-05-31 |
Julien Gander
LAW | General Counsel | 47 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jean-Paul Clozel
CHM | Chairman | 70 | 2024-06-12 |
Mathieu Simon
CHM | Chairman | 69 | 2020-05-12 |
Sandy Mahatme
BRD | Director/Board Member | 61 | 2020-05-12 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -0.32% | 0% | 50 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -4.29% | -10.60% | +190.70% | -72.74% | 1.18B | |
| -0.99% | -5.69% | +7.23% | +92.79% | 44.3B | |
| +0.47% | -5.67% | +54.34% | +11.05% | 40B | |
| -0.79% | -4.35% | +90.40% | +595.09% | 30.95B | |
| -1.68% | -9.38% | -9.87% | -24.06% | 25.58B | |
| +2.54% | -5.07% | +57.32% | -37.07% | 18.76B | |
| -2.07% | -6.41% | +5.42% | -32.29% | 16.89B | |
| +5.20% | +5.30% | +46.09% | +144.70% | 12.02B | |
| -0.54% | -11.21% | -22.43% | +959.71% | 11.58B | |
| +4.43% | +1.36% | +59.06% | - | 11.03B | |
| Average | +0.20% | -4.65% | +47.83% | +181.91% | 21.23B | |
| Weighted average by Cap. | +0.07% | -4.68% | +34.74% | +168.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 265M 339M 293M 255M 464M 31.1B 485M 3.14B 1.25B 14.9B 1.27B 1.24B 53.42B | 282M 360M 311M 270M 493M 33.03B 515M 3.33B 1.33B 15.83B 1.35B 1.32B 56.75B |
| Net income | -88.68M -113M -97.93M -85.13M -155M -10.4B -162M -1.05B -419M -4.98B -425M -416M -17.87B | 13.81M 17.64M 15.25M 13.26M 24.19M 1.62B 25.25M 163M 65.3M 776M 66.2M 64.78M 2.78B |
| Net Debt | 1.03B 1.32B 1.14B 993M 1.81B 121B 1.89B 12.23B 4.89B 58.09B 4.95B 4.85B 208B | 1.2B 1.53B 1.33B 1.15B 2.1B 141B 2.2B 14.21B 5.68B 67.51B 5.76B 5.64B 242B |
Employees
650
Calendar
Apr. 28 -
Earnings release - Q1 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-06 | 3.500 CHF | -4.37% | 2,703,267 |
| 26-03-05 | 3.660 CHF | -2.92% | 1,674,460 |
| 26-03-04 | 3.770 CHF | -7.26% | 2,262,159 |
| 26-03-03 | 4.065 CHF | -1.22% | 1,647,783 |
| 26-03-02 | 4.115 CHF | +5.11% | 3,164,598 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.660CHF
Average target price
4.833CHF
Spread / Average Target
+32.06%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- IDIA Stock
Select your edition
All financial news and data tailored to specific country editions
